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SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comBackground: A transradial (TR) approach for percutaneous coronary intervention
(PCI) signiﬁcantly reduces bleeding and vascular complications compared to the
transfemoral (TF) approach. However, many patients undergoing PCI return for repeat
procedures over time and limited data is available to guide the choice of TR vs TF
approach in these patients. The present study compared procedural success and
adverse outcomes of TR and TF approach in patients undergoing successive PCI
procedures.
Methods: Baseline clinical, procedural and outcome data for patients undergoing
successive ipsilateral TR or TF approach for PCI were compared. The primary
outcome was procedural success deﬁned as completion of PCI by ipsilateral TR.
Results: A total of 634 and 2195 patients underwent  2 PCI procedures by ipsilateral
TR and TF approach respectively. The baseline characteristics, procedural parameters,
clinical outcomes and vascular complications of the study group are shown in the
Table.2PCI 3PCI 4PCI
TR-All
(n¼634)
TF-ALL
(n¼ 2195)
RADIAL
(n¼509)
FEMORAL
(n¼ 1376)
RADIAL
(n¼96)
FEMORAL
(n¼569)
RADIAL
(n¼29)
FEMORAL
(n¼250)
Procedural parameters
Fluoro time, minutes (meanSD)
189 1710* 189 1711 199 179* 228 178*
Contrast volume, ml (meanSD) 19473 19975 19676 20278 18463 19266 18853 19461
Guides per patient (meanSD) 1.10.3 1.20.4* 1.20.3 1.20.5 1.10.2 1.10.3 1.10.2 1.10.3
Stent per patient (meanSD) 2.71.6 2.82.2 2.61.5 2.51.8 2.91.8 3.12.4 3.31.8 3.41.7
Clinical outcomes
Procedural failure (%)
42 (7) 3 (0.1)* 33 (6) 2 (0.1)* 7 (7) 0 (0)* 2 (7) 1 (0.4)*
In hospital death (%) 0 (0) 6 (0.3) 0 (0) 2 (0.1) 0 (0) 3 (0.5) 0 (0) 1 (0.4)
Stroke (%) 0 (0) 10 (0.4) 0 (0) 6 (0.4) 0 (0) 2 (0.3) 0 (0) 2 (0.8)
Transfusion (%) 1 (0.2) 8 (0.4) 1 (0.2) 6 (0.4) 0 (0) 2 (0.3) 0 (0) 0 (0)
D eGFR (meanSD) 718 623 617 519 1019 725 618 532
Access site complications
Bleeding (%)
2 (0.3) 20 (0.9) 2 (0.4) 13 (0.9) 0 (0) 7 (1.2) 0 (0) 0 (0)
Pseudoaneurysm (%) 0 (0) 22 (1) * 0 (0) 18 (1.3) * 0 (0) 4 (0.7) 0 (0) 0 (0)
Any vascular complication (%) 12 (1.9) 88 (4) * 10 (2) 66 (4.8) * 2 (2.1) 19 (3.3) 0 (0) 3 (1.2)
CABG-coronary artery bypass surgery, MACE-major adverse cardiac events, D eGFR-increase in estimated glomerular ﬁltration rate post procedure, *p<0.05Conclusions: Successive ipsilateral TR approach can be accomplished in more than
90% of patients undergoing repeat PCI with no clinically important difference in
radiation exposure and contrast usage. In addition, TR approach results in a signiﬁ-
cantly lower risk of vascular complications and similar clinical outcomes compared to
the transfemoral approach. TR approach should be the preferred therapy for patients
undergoing repeat PCI.TCT-820
How to limit radial artery spasm in patients treated by transradial interventions
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Background: Radial artery spasm (RAS) remains the major limitation for transradial
approach, especially among transfemoralists physicians. Our team has performed three
successive randomized controlled trials sharing similar methodology and endpoints
and evaluating different vasodilator agents in the prevention of RAS. We are reporting
the results of the pooled analysis of our three studies.
Methods: A total of 1,950 patients were consecutively randomized to receive dilti-
azem, verapamil, molsidomine, isosorbide dinitrate (ISDN) or placebo, through the
arterial sheath after radial artery catheterization. The primary endpoint was the
occurrence of a RAS deﬁned as a limitation of the catheter movement and/or a sig-
niﬁcant pain perceived by the patient during catheter mobilization. Secondary end-
points included the occurrence of symptomatic or signiﬁcant fall of systolic blood
pressure and determination of independent predictors of RAS.
Results: RAS occurred in 44/198 patients (22.22 %) in the placebo group with a
signiﬁcant reduction in the molsidomine 27/203 (13.3%) and verapamil 88/847
(10.4%) group (P¼0.02). The rate of occurrence of RAS was similar between the
placebo, IDN and diltiazem groups (P¼0.2). Signiﬁcant fall of blood pressure
occurred signiﬁcantly more with diltiazem and ISDN compared to placebo or other
vasodilators (p¼0.001). Female gender and the use of more than 3 catheters were
identiﬁed as independent predictors of RAS.
Conclusions: Among vasodilators verapamil and/or molsidomine showed the best
efﬁcacy to prevent RAS without affecting patient safety. Their use reduces the
occurrence of RAS more than 50%. ISDN and diltiazem should be avoided as they
don’t prevent RAS.B240 JACC Vol 64/11/Suppl B j September 1TCT-821
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Background: The small proﬁle of a 4-Fr guiding catheter may reduce complications
associated with vascular access. In this study, we investigated the hypothesis whether
the use of a 4-Fr guiding catheter would have a lower rate of radial artery occlusion
compared with the use of a 6-Fr guiding catheter.
Methods: The study was conducted at 19 institutions across Asia. The frequency of
radial artery occlusion was compared between patients receiving 4-Fr vs. 6-Fr trans-
radial coronary interventions (TRI) in an open-label randomized trial (ClinicalTrials.
gov identiﬁer: NCT00815997). The primary outcome measure was radial artery oc-
clusion on the day after TRI. The secondary outcome measures were the procedural
success, major advanced cardiac events, access-site-related complications, procedural
times, ﬂuoroscopy times, and contrast dye usage.
Results: The present study comprised a total of 160 patients divided into 2 groups,
those who underwent 4-Fr TRI and those who underwent 6-Fr TRI. The procedure
was successful in 79 of 80 patients (99%) in both groups. While the 4-Fr group
showed no access-site-related complications, the 6-Fr developed 5 (6%), including 3
radial artery occlusions and 2 bleedings (1 radial artery perforation and 1 massive
hematoma) (p¼0.02). Although the radial artery occlusion rate was lower in the 4-Fr
vs. in the 6-Fr groups, the difference was not signiﬁcant (0% vs. 4%, p¼0.08). The
mean hemostasis time was signiﬁcantly shorter in the 4-Fr than in the 6-Fr groups (237
 105 min vs. 320  238 min, p¼0.007).
Conclusions: The current study demonstrates that 4-Fr TRI could deliver procedural
success rates that are comparable to 6-Fr TRI, with shorter times to hemostasis and
fewer access-site-related complications. Furthermore, 4-Fr TRI may reduce radial
artery occlusions. Hence, these ﬁndings suggest that 4-Fr PCI may provide a less
invasive approach to treat coronary artery diseases.TCT-822
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Background: The use of compression of the other artery [(COOA):ulnar compression
for radial access and vice versa], could increase access artery diameter(AAD)(via
collateral ﬂow through palmar arch) thus reducing puncture failure in small arteries,
which is a major challenge of transradial access in women; another being risk
of >1:1mismatch of small AADs with sheath size and consequent AA spasm. We
aimed to assess AADs (bilateral RA&UA); prevalence of a ‘single largest’
AA(with remaining 3AAs being smaller by >0.2mm(>0.1mm in 1.5mm group)) in
various size groups, in females compared to males; comparison of crossover, proce-
dure failure & AA occlusion (at 4 weeks)in < 1.7mm vs 1.7mm AAD groups; and
impact of COOA on puncture failures in patients with single largest AAD¼ 1.5,1.6 or
1.7mm.
Methods: AADs were measured using pre-procedure ultrasound (PPUAA). COOA
(for 5 minutes) was randomly utilized at the time of elective procedures, in 50%
patients in whom the single largest AAD was 1.5, 1.6 or 1.7mm. 1.5mm arteries were
used for coronary angiogram(CAG);1.6mm were used for percutaneous coronary
intervention(PCI).
Results: A total of 1110 patients: 264 females (F) & 846 males (M) were enrolled.
The baseline mean AADs(mm) were larger in males (1.820.2(radial(RA)),1.78-
0.2(ulnar(UA)) vs 1.710.2(RA),1.600.2(UA))(p< 0.001). Females more often
had only one largest AAD in the 1.5mm ((17.1%(F) vs 7.8%(M),1.6mm (9.6% (F) vs
3.8% (M)) and 1.7mm groups (10.6% (F) vs 4.5% (M) groups (p< 0.001). Again,
females more commonly had single largest AA in the 1.8-2.0mm group ( 42.8% (F) vs
29.7% (M), p< 0.001). With COOA, the AAD increased by 16.6+6%; 14.53%
&124.2% in the 1.5,1.6 &1.7mm groups respectively and puncture success was 78%
vs 98%(p< 0.001), 88% vs 97.8% (P< 0.001) and 96.7% vs 98.5%(p¼0.06) with and
without COOA respectively. Crossover (&procedure failure)& AA occlusion were
3.9% vs 0.9% & 2.8% vs 0.8% respectively (p< 0.0001) in the < 1.7mm vs 1.7mm
AAD groups.
Conclusions: Females more commonly have only one large AA, compared to
men. In the 1.5-1.6mm AAs, the use of COOA reduces puncture failures. Smaller
AAs(< 1.7mm), are associated with higher cross-over, procedure failure & AA
occlusion.3–17, 2014 j TCT Abstracts/Vascular Access and Intervention - Transradial
